Ma Songjiang, President and Director of Gyre Therapeutics, Inc. (NASDAQ:GYRE), recently sold shares in the company totaling $45,434, according to a recent SEC filing. The transactions occurred over ...
Good afternoon, and welcome to the Equinix fourth quarter earnings conference call. All lines will be able to listen only ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback